Clinical Trials Directory

Trials / Completed

CompletedNCT02203214

Induced ACL Healing With the Ligamys Technique: a Prospective, Multicenter Observational Case Series

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
Mathys Ltd Bettlach · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and effectiveness of the Ligamys technique for the treatment of acute ruptures of the anterior cruciate ligament in a multicenter routine clinical setting. To conduct a long-term follow-up of the case series as a post-market product surveillance endeavor.

Detailed description

The Ligamys method was successfully applied in an animal study including eleven white alpine sheep. Healing of the torn ACL and a stable joint without signs of intra-articular damages or osteoarthritis three months postoperative were observed (Kohl KSSTA 2013). In a first clinical study with ten patients, the Ligamys surgical technique resulted in stable clinical and radiological healing of the torn ACL in nine patients with one re-rupture after four months. Nine patients obtained normal knee scores, reported excellent patient satisfaction, and could return to their previous levels of sporting activity (Kohl Swiss Med Wkly 2011). The purpose of this study is to evaluate the safety and effectiveness of the Ligamys technique for the treatment of acute ruptures of the anterior cruciate ligament in a multicenter routine clinical setting. To conduct a long-term follow-up of the case series as a post-market product surveillance endeavor.

Conditions

Interventions

TypeNameDescription
DEVICELigamysAll patients are treated with Ligamys within 21 days after injury. The Ligamys implant has to be used in accordance with the instructions for use.

Timeline

Start date
2013-08-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2014-07-29
Last updated
2018-08-17

Locations

3 sites across 3 countries: Belgium, Germany, Switzerland

Source: ClinicalTrials.gov record NCT02203214. Inclusion in this directory is not an endorsement.